AAAAAA
Results:
1-18
|
Results: 18
Authors:
Fernebro, E
Madsen, RR
Ferno, M
Brunner, N
Bendahl, PO
Christensen, IJ
Johnson, A
Nilbert, M
Citation: E. Fernebro et al., Prognostic importance of the soluble plasminogen activator receptor; suPAR, in plasma from rectal cancer patients, EUR J CANC, 37(4), 2001, pp. 486-491
Authors:
Fredstorp-Lidebring, M
Bendahl, PO
Brunner, N
Casslen, B
Hogberg, T
Langstrom-Einarsson, E
Willen, R
Ferno, M
Citation: M. Fredstorp-lidebring et al., Urokinase plasminogen activator and its inhibitor, PAI-1, in association with progression-free survival in early stage endometrial cancer, EUR J CANC, 37(18), 2001, pp. 2339-2348
Authors:
Ringberg, A
Anagnostaki, L
Anderson, H
Idvall, I
Ferno, M
Citation: A. Ringberg et al., Cell biological factors in ductal carcinoma in situ (DCIS) of the breast-relationship to ipsilateral local recurrence and histopathological characteristics, EUR J CANC, 37(12), 2001, pp. 1514-1522
Authors:
Idvall, I
Andersson, C
Fallenius, G
Ingvar, C
Ringberg, A
Strand, C
Akerman, M
Ferno, M
Citation: I. Idvall et al., Histopathological and cell biological factors of ductal carcinoma in situ before and after the introduction of mammographic screening, ACTA ONCOL, 40(5), 2001, pp. 653-659
Authors:
Rudolph, P
Alm, P
Olsson, H
Heidebrecht, HJ
Ferno, M
Baldetorp, B
Parwaresch, R
Citation: P. Rudolph et al., Concurrent overexpression of p53 and c-erbB-2 correlates with accelerated cycling and concomitant poor prognosis in node-negative breast cancer, HUMAN PATH, 32(3), 2001, pp. 311-319
Authors:
Andersson, C
Lydrup, ML
Ferno, M
Idvall, I
Gustafsson, JA
Nilsson, BO
Citation: C. Andersson et al., Immunocytochemical demonstration of oestrogen receptor beta in blood vessels of the female rat, J ENDOCR, 169(2), 2001, pp. 241-247
Authors:
Romain, S
Bendahl, PO
Guirou, O
Malmstrom, P
Martin, PM
Ferno, M
Citation: S. Romain et al., DNA-synthesizing enzymes in breast cancer (thymidine kinase, thymidylate synthase and thymidylate kinase): Association with flow cytometric S-phase fraction and relative prognostic importance in node-negative premenopausal patients, INT J CANC, 95(1), 2001, pp. 56-61
Authors:
Gruvberger, S
Ringner, M
Chen, YD
Panavally, S
Saal, LH
Borg, A
Ferno, M
Peterson, C
Meltzer, PS
Citation: S. Gruvberger et al., Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns, CANCER RES, 61(16), 2001, pp. 5979-5984
Authors:
Stal, O
Borg, A
Ferno, M
Kallstrom, AC
Malmstrom, P
Nordenskjold, B
Citation: O. Stal et al., ErbB2 status and the benefit from two or five years of adjuvant tamoxifen in postmenopausal early stage breast cancer, ANN ONCOL, 11(12), 2000, pp. 1545-1550
Authors:
Ringberg, A
Idvall, I
Ferno, M
Anderson, H
Anagnostaki, L
Boiesen, P
Bondesson, L
Holm, E
Johansson, S
Lindholm, K
Ljungberg, O
Ostberg, G
Citation: A. Ringberg et al., Ipsilateral local recurrence in relation to therapy and morphological characteristics in patients with ductal carcinoma in situ of the breast, EUR J SUR O, 26(5), 2000, pp. 444-451
Authors:
Malmstrom, P
Bendahl, PO
Boiesen, P
Brunner, N
Idvall, I
Ferno, M
Citation: P. Malmstrom et al., S-phase fraction and urokinase plasminogen activator are better markers for distant recurrences than Nottingham Prognostic Index and histologic gradein a prospective study of premenopausal lymph node-negative breast cancer, J CL ONCOL, 19(7), 2000, pp. 2010-2019
Authors:
Boiesen, P
Bendahl, PO
Anagnostaki, L
Domanski, H
Holm, E
Idvall, I
Johansson, S
Ljungberg, O
Ringberg, A
Ostberg, G
Ferno, M
Citation: P. Boiesen et al., Histologic grading in breast cancer - Reproducibility between seven pathologic departments, ACTA ONCOL, 39(1), 2000, pp. 41-45
Results of two or five years of adjuvant tamoxifen correlated to steroid receptor and S-phase levels
Authors:
Ferno, M
Stal, O
Baldetrop, B
Hatschek, T
Kallstrom, AC
Malmstrom, P
Nordenskjold, B
Ryden, S
Citation: M. Ferno et al., Results of two or five years of adjuvant tamoxifen correlated to steroid receptor and S-phase levels, BREAST CANC, 59(1), 2000, pp. 69-76
Immunologic proliferation marker Ki-S2 as prognostic indicator for lymph node-negative breast cancer
Authors:
Rudolph, P
Alm, P
Heidebrecht, HJ
Bolte, H
Ratjen, V
Baldetorp, B
Ferno, M
Olsson, H
Parwaresch, R
Citation: P. Rudolph et al., Immunologic proliferation marker Ki-S2 as prognostic indicator for lymph node-negative breast cancer, J NAT CANC, 91(3), 1999, pp. 271-278
Authors:
Rudolph, P
Olsson, H
Bonatz, G
Ratjen, V
Bolte, H
Baldetorp, B
Ferno, M
Parwaresch, R
Alm, P
Citation: P. Rudolph et al., Correlation between p53, c-erbB-2, and topoisomerase II alpha expression, DNA ploidy, hormonal receptor status and proliferation in 356 node-negativebreast carcinomas: Prognostic implications, J PATHOLOGY, 187(2), 1999, pp. 207-216
Authors:
Loman, N
Johannsson, O
Bendahl, PO
Borg, A
Ferno, M
Olsson, H
Citation: N. Loman et al., Steroid receptors in hereditary breast carcinomas associated with BRCA1 orBRCA2 mutations or unknown susceptibility genes - Reply, CANCER, 85(10), 1999, pp. 2293-2295
Authors:
Jernstrom, H
Frenander, J
Ferno, M
Olsson, H
Citation: H. Jernstrom et al., Hormone replacement therapy before breast cancer diagnosis significantly reduces the overall death rate compared with never-use among 984 breast cancer patients, BR J CANC, 80(9), 1999, pp. 1453-1458
Authors:
Gustafson, P
Baldetorp, B
Ferno, M
Akerman, M
Citation: P. Gustafson et al., Prognostic implications of various models for calculation of S-phase fraction in 259 patients with soft tissue sarcoma, BR J CANC, 79(7-8), 1999, pp. 1205-1209
Risultati:
1-18
|